Jefferies upgrades Spire Healthcare to ‘buy’

by | Mar 31, 2023

Jefferies upgraded Spire Healthcare on Friday to ‘buy’ from ‘hold’ and lifted the price target to 250p from 240p, arguing that the market is underappreciating the company’s growth opportunity.
It said that despite overall macro concerns, it is encouraged by resilient UK healthcare market conditions.

It said that Spire’s recent performance under-appreciates its growth opportunity “given the particular UK healthcare market dynamics with a significant NHS waiting list and labour challenges”.

“We bake in inflationary pressures (mainly salary), and believe that both pricing and demand could help SPI manage its cost headwinds, providing resilience to its profitability,” it said. “In our view, market concerns are likely to be alleviated with enhanced confidence in the company’s outlook from 2H’23.”

Jefferies said the improvement of profitability and management focus on asset efficiency should also improve return to shareholders.

A1045 BST, the shares were up 1.6% at 215p.

Related articles

RBC Capital cuts Rentokil price target

RBC Capital cuts Rentokil price target

(Sharecast News) - RBC Capital Markets cut its price target on Rentokil Initial on Wednesday to 575p from 610p as it downgraded forecasts for forex and a greater back-end loading of TMX synergies, but said it believes the long-term story remains intact. The bank said...

Trending stories

Join our mailing list

Subscribe to our mailing list to receive regular updates!